Dr. Della'Zanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2001 Medical Pkwy
Annapolis, MD 21401Phone+1 443-481-1000Fax+1 443-481-1360
Education & Training
Philadelphia College of Osteopathic MedicineM.Sc., Vascular Surgery , 1996 - 1998- Albright CollegeB.S., Biology, 1998
Philadelphia College of Osteopathic MedicineResidency, Surgery, 1992 - 1997- Philadelphia College of Osteopathic MedicineClass of 1992
- Philadelphia College of Osteopathic MedicineM.C.Sc., Vascular Surgery
Certifications & Licensure
MD State License 2004 - 2026
GA State License 1997 - 2005
PA State License 1993 - 2002- AOA Board of Surgery Surgery
- National Institutes of Health: Clinical Research CurriculumClinical Research Curriculum
Awards, Honors, & Recognition
- Certificate with Commendation, Clinical Research Curriculum National Institutes of Health, 2010
- FDA Group Recognition Award 2007
- CDER Team Excellence Award 2003, 2005
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsPhase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.David S. Weinberg, Nathan R. Foster, Gary Della'Zanna, Ryan McMurray, Walter K. Kraft
Cancer Biology & Therapy. 2021-10-10 - 12 citationsRandomized phase II trial of polyphenon E versus placebo in patients at high risk of recurrent colonic neoplasiaFrank A. Sinicrope, Thomas R. Viggiano, Navtej S. Buttar, Louis M. Wong Kee Song, Kenneth W. Schroeder
Cancer Prevention Research. 2021-03-01 - 32 citationsBioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.David S. Weinberg, Jieru E. Lin, Nathan R. Foster, Gary Della'Zanna, Asad Umar
Cancer Prevention Research. 2017-06-01
Journal Articles
- A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E(2) in Patients With Barrett's EsophagusFalk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Wei..., Gastroenterology, 1/11/2012
- Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous NeoplasmsSteven Lipkin, John Lee, David Imagawa, Stephen M. Hewitt, Chris Tucker, Jason A. Zell, Vanessa Wong, Angela Garcia, Rachel Gonzalez, Gary Della Zanna, Ellen Richmond,..., Cancer Prev Res, 1/1/2011
Abstracts/Posters
- Aspirin Mediated Down-Regulation of Warburg Kinase AKT1 in Patients with Barrett's Esophagus: Implications in Neoplastic TransformationNavtej S. Buttar; Gary W. Falk; Cathrine J. DeMars; Sonia Chowdhury; Ahmed Elebiary; Anamay Sharma; Sidhartha Chaudhry; Nathan R. Foster; Katie L. Allen Ziegler; Yvonn..., Eleventh Annual AACR International Conference: Frontiers in Cancer Prevention Research, 1/16/2012
Professional Memberships
- Member
- Fellow
External Links
- National Cancer Institute's Division of Cancer Preventionhttps://prevention.cancer.gov/
- National Cancer Institutehttp://www.cancer.gov/
- National Institutes of Healthhttp://www.nih.gov/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
